Market Overview:
The global avascular necrosis market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The growth in the market can be attributed to factors such as increasing incidence of AVN, rising geriatric population, and technological advancements in the field of diagnosis and treatment. However, the high cost of treatment is expected to restrain the growth of this market during the forecast period. Based on type, trauma-related avascular necrosis (AVN) accounted for the majority share in 2017 and is projected to maintain its dominance during the forecast period. This can be attributed to increasing incidence of traumatic injuries across globe. Non-trauma related AVN is expected to grow at a higher CAGR from 2018to 2030 owingto increase incidencesof non-traumatic causes such as long term use offluoroquinolones antibioticsand steroid therapyfor various diseases such as rheumatoid arthritisand lupus erythematosus .
Product Definition:
Avascular necrosis (AVN) is a medical condition in which bone tissue dies due to interruption of the blood supply. This often leads to the collapse of one or more bones.
Trauma Related Avascular Necrosis (AVN):
AVN is caused by the death of a blood vessel that supplies oxygen-rich blood to an area. The most common symptom associated with AVN is pain in the affected part, which may be located anywhere from just below the rib cage on down toward the foot or it can extend all through the upper body. AVN usually affects arteries and veins that supply oxygen-rich blood to tissues and organs such as kidneys, liver, heart, brain and lungs.
Non-Trauma Related Avascular Necrosis (AVN):
AVN is caused by the absence of a blood supply to any part of the body. AVN can affect any organ in the human body such as kidney, liver, spleen and heart. It also affects other parts of the body such as bone marrow, gastrointestinal tract and lungs.
Application Insights:
The hospital segment dominated the market in 2017 and is expected to continue its dominance over the forecast period. This can be attributed to factors such as a high incidence of trauma cases, which require immediate surgical intervention. Furthermore, rising awareness about timely diagnosis and treatment of AVN is anticipated to boost the growth of this segment in near future. The outpatient clinics segment is also expected to witness significant growth during the forecast period owing to increasing awareness among general practitioners (GPs) regarding timely treatment for AVN so that there's no permanent disability or death caused by avascular necrosis.
AVascular diseases are one of the most common conditions affecting older people; thus, it's important for geriatric patients suffering from various symptoms including pain in legs & feet, breathlessness on exertion and weight loss due largely but not exclusively these disorders being under-diagnosed or undiagnosed leading often times resulting premature deaths due Avascular Necrosis (AVN).
Regional Analysis:
In 2017, North America dominated the global market with a share of over 45.0% owing to the increasing prevalence of diabetes and hypertension in this region. According to CDC, around 60 million people in U.S. have hypertension and nearly 7 million people have diabetes; these are the major factors contributing toward the high incidence rate of AVN observed in this region [1].
Asia Pacific is expected to grow at a lucrative CAGR during the forecast period due its low cost coupled with favorable government initiatives for improving healthcare infrastructure especially pertaining towards diagnostics & treatment options for avascular necrosis patients resulting into higher adoption rates compared with other developed regions [2].
Growth Factors:
- Increasing incidence of Avascular Necrosis (AVN) due to rising prevalence of risk factors such as obesity, diabetes mellitus, and smoking.
- Growing demand for better treatment options for AVN patients.
- Rising awareness about AVN and its treatment options among people worldwide.
- Technological advancements in the field of AVN treatment that offer improved outcomes to patients.
- increasing number of clinical studies on new therapies for avascular necrosis that are expected to result in better treatments options in the near future
Scope Of The Report
Report Attributes
Report Details
Report Title
Avascular Necrosis Market Research Report
By Type
Trauma Related Avascular Necrosis (AVN), Non-Trauma Related Avascular Necrosis (AVN)
By Application
Hospitals, Clinics, Diagnostic Centers, Ambulatory Surgical Centers, Others
By Companies
Stryker, Medtronic, Smith and Nephew, Ethicon, Sanofi, Bayer, Pfizer, Merck, Boehringer Ingelheim, Eli Lilly, Aurobindo Pharma, Integra LifeSciences, Zimmer Biomet, Wright Medical, Grifols
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
191
Number of Tables & Figures
134
Customization Available
Yes, the report can be customized as per your need.
Global Avascular Necrosis Market Report Segments:
The global Avascular Necrosis market is segmented on the basis of:
Types
Trauma Related Avascular Necrosis (AVN), Non-Trauma Related Avascular Necrosis (AVN)
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics, Diagnostic Centers, Ambulatory Surgical Centers, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Stryker
- Medtronic
- Smith and Nephew
- Ethicon
- Sanofi
- Bayer
- Pfizer
- Merck
- Boehringer Ingelheim
- Eli Lilly
- Aurobindo Pharma
- Integra LifeSciences
- Zimmer Biomet
- Wright Medical
- Grifols
Highlights of The Avascular Necrosis Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Trauma Related Avascular Necrosis (AVN)
- Non-Trauma Related Avascular Necrosis (AVN)
- By Application:
- Hospitals
- Clinics
- Diagnostic Centers
- Ambulatory Surgical Centers
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Avascular Necrosis Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Avascular necrosis is a condition in which the blood supply to a part of the body is interrupted. This can happen due to injury, disease, or age. The affected area may become swollen and red, and may eventually die due to lack of blood flow.
Some of the major companies in the avascular necrosis market are Stryker, Medtronic, Smith and Nephew, Ethicon, Sanofi, Bayer, Pfizer, Merck, Boehringer Ingelheim, Eli Lilly, Aurobindo Pharma, Integra LifeSciences, Zimmer Biomet, Wright Medical, Grifols.
The avascular necrosis market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Avascular Necrosis Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Avascular Necrosis Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Avascular Necrosis Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Avascular Necrosis Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Avascular Necrosis Market Size & Forecast, 2020-2028
4.5.1 Avascular Necrosis Market Size and Y-o-Y Growth
4.5.2 Avascular Necrosis Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Trauma Related Avascular Necrosis (AVN)
5.2.2 Non-Trauma Related Avascular Necrosis (AVN)
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Clinics
6.2.3 Diagnostic Centers
6.2.4 Ambulatory Surgical Centers
6.2.5 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Avascular Necrosis Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Avascular Necrosis Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Trauma Related Avascular Necrosis (AVN)
9.6.2 Non-Trauma Related Avascular Necrosis (AVN)
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Clinics
9.10.3 Diagnostic Centers
9.10.4 Ambulatory Surgical Centers
9.10.5 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Trauma Related Avascular Necrosis (AVN)
10.6.2 Non-Trauma Related Avascular Necrosis (AVN)
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Clinics
10.10.3 Diagnostic Centers
10.10.4 Ambulatory Surgical Centers
10.10.5 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Trauma Related Avascular Necrosis (AVN)
11.6.2 Non-Trauma Related Avascular Necrosis (AVN)
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Clinics
11.10.3 Diagnostic Centers
11.10.4 Ambulatory Surgical Centers
11.10.5 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Trauma Related Avascular Necrosis (AVN)
12.6.2 Non-Trauma Related Avascular Necrosis (AVN)
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Clinics
12.10.3 Diagnostic Centers
12.10.4 Ambulatory Surgical Centers
12.10.5 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Trauma Related Avascular Necrosis (AVN)
13.6.2 Non-Trauma Related Avascular Necrosis (AVN)
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Clinics
13.10.3 Diagnostic Centers
13.10.4 Ambulatory Surgical Centers
13.10.5 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Avascular Necrosis Market: Competitive Dashboard
14.2 Global Avascular Necrosis Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Stryker
14.3.2 Medtronic
14.3.3 Smith and Nephew
14.3.4 Ethicon
14.3.5 Sanofi
14.3.6 Bayer
14.3.7 Pfizer
14.3.8 Merck
14.3.9 Boehringer Ingelheim
14.3.10 Eli Lilly
14.3.11 Aurobindo Pharma
14.3.12 Integra LifeSciences
14.3.13 Zimmer Biomet
14.3.14 Wright Medical
14.3.15 Grifols
